Skip to content

Application of Bronchial Blocker in Minimally Invasive Cardiac Surgery

Bronchial Blocker in Blocking the Right Middle Lower Lobe Versus Double-Lumen Endotracheal Tube for One-Lung Ventilation in Minimally Invasive Cardiac Surgery

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03505242
Enrollment
48
Registered
2018-04-23
Start date
2018-05-01
Completion date
2020-05-01
Last updated
2018-04-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Minimally Invasive Cardiac Surgery

Brief summary

Both left single lung ventilation by left double lumen tube and bilateral ventilation with selective blockage of right middle lower lobe by bronchial blocker can provide suitable surgical field for minimally invasive cardiac surgery. The current study was designed to compare the impact of these two different methods on oxygenation, degree of pulmonary collapse and postoperative complications.

Interventions

DEVICEbronchial blocker for BB group

Using bronchial blocker to block right middle lower lobe during surgery.

DEVICEdouble lumen tube for DLT group

Using double lumen tube to achieve single lung ventilation during surgery.

Sponsors

Shanghai Zhongshan Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to 70 Years
Healthy volunteers
No

Inclusion criteria

* ASA II-III * BMI 18-31 * elective minimally invasive cardiac surgery by right thoracotomy

Exclusion criteria

* asthma * COPD * previous lung surgery * previous cardiac surgery

Design outcomes

Primary

MeasureTime frameDescription
oxygenationintraoperativerecord SpO2 and PaO2 during selective ventilation

Secondary

MeasureTime frameDescription
degree of pulmonary collapseintraoperativesurgeon score the degree of pulmonary collapse (1 for no pulmonary collapse and 5 for excellent pulmonary collapse)

Contacts

Primary ContactKefang Guo
guo.kefang@zs-hospital.sh.cn+8613817706936
Backup ContactLin Jin
jin.lin@zs-hospital.sh.cn+8613917131195

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026